All Older Adults Benefit From Pneumococcal Vaccinations-The Case for Evaluating Vaccine Effectiveness Using All-Cause Pneumonia

JAMA Intern Med. 2023 Jan 1;183(1):48-49. doi: 10.1001/jamainternmed.2022.5456.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Humans
  • Immunization
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • Pneumonia* / prevention & control
  • Pneumonia, Pneumococcal* / prevention & control
  • Vaccination
  • Vaccine Efficacy

Substances

  • Pneumococcal Vaccines